From October 1, 2022 to December 31, 2022, the company has repurchased 476,085 shares, representing 0.57% for $1.83 million. With this, the company has completed the repurchase of 718,496 shares, representing 0.87% for $3 million under the buyback announced on August 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | 0.00% | 0.00% | -7.89% |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.89% | 141M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- Tranche Update on I-Mab's Equity Buyback Plan announced on August 30, 2022.